CONMED Corporation (CNMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CONMED Corporation (CNMD) has a cash flow conversion efficiency ratio of 0.013x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($13.47 Million) by net assets ($1.02 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CNMD days of operational coverage to measure how many days the company can operate on defensive assets alone.
CONMED Corporation - Cash Flow Conversion Efficiency Trend (1990–2025)
This chart illustrates how CONMED Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.
CONMED Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CONMED Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Verusa Holding AS
IS:VERUS
|
-0.014x |
|
Jiaxing ZMAX Optech Co. Ltd. A
SHG:688307
|
N/A |
|
Weihai Honglin Electronic Co. Ltd. A
SHE:301439
|
N/A |
|
ZKTECO Co. Ltd. A
SHE:301330
|
N/A |
|
Alphamin Resources Corp
F:21L
|
N/A |
|
Cathay Real Estate Development Co Ltd
TW:2501
|
0.003x |
|
EUREKA FORBES LTD
NSE:EUREKAFORB
|
-0.005x |
|
Khang Dien House Trading and Investment JSC
VN:KDH
|
-0.029x |
Annual Cash Flow Conversion Efficiency for CONMED Corporation (1990–2025)
The table below shows the annual cash flow conversion efficiency of CONMED Corporation from 1990 to 2025. For the full company profile with market capitalisation and key ratios, see CONMED Corporation (CNMD) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.03 Billion | $170.69 Million | 0.165x | -4.74% |
| 2024-12-31 | $962.68 Million | $166.97 Million | 0.173x | +15.43% |
| 2023-12-31 | $834.22 Million | $125.35 Million | 0.150x | +235.75% |
| 2022-12-31 | $745.54 Million | $33.37 Million | 0.045x | -68.55% |
| 2021-12-31 | $785.43 Million | $111.77 Million | 0.142x | +56.36% |
| 2020-12-31 | $709.04 Million | $64.53 Million | 0.091x | -32.03% |
| 2019-12-31 | $710.47 Million | $95.13 Million | 0.134x | +18.71% |
| 2018-12-31 | $662.27 Million | $74.70 Million | 0.113x | +8.63% |
| 2017-12-31 | $631.43 Million | $65.57 Million | 0.104x | +57.72% |
| 2016-12-31 | $580.58 Million | $38.22 Million | 0.066x | -19.87% |
| 2015-12-31 | $585.07 Million | $48.07 Million | 0.082x | -26.72% |
| 2014-12-31 | $581.30 Million | $65.18 Million | 0.112x | -16.02% |
| 2013-12-31 | $606.32 Million | $80.95 Million | 0.134x | -14.87% |
| 2012-12-31 | $607.00 Million | $95.20 Million | 0.157x | -12.73% |
| 2011-12-31 | $573.07 Million | $102.99 Million | 0.180x | +175.65% |
| 2010-12-31 | $586.56 Million | $38.24 Million | 0.065x | +50.18% |
| 2009-12-31 | $576.51 Million | $25.03 Million | 0.043x | -62.25% |
| 2008-12-31 | $531.73 Million | $61.15 Million | 0.115x | -11.87% |
| 2007-12-31 | $505.00 Million | $65.89 Million | 0.130x | -11.02% |
| 2006-12-31 | $440.35 Million | $64.57 Million | 0.147x | +56.54% |
| 2005-12-31 | $453.01 Million | $42.43 Million | 0.094x | -43.93% |
| 2004-12-31 | $447.98 Million | $74.84 Million | 0.167x | +24.84% |
| 2003-12-31 | $433.49 Million | $58.01 Million | 0.134x | +15.27% |
| 2002-12-31 | $386.94 Million | $44.92 Million | 0.116x | -57.32% |
| 2001-12-31 | $283.63 Million | $77.15 Million | 0.272x | +74.48% |
| 2000-12-31 | $230.60 Million | $35.95 Million | 0.156x | -10.97% |
| 1999-12-31 | $211.30 Million | $37.00 Million | 0.175x | +51.93% |
| 1998-12-31 | $182.20 Million | $21.00 Million | 0.115x | -41.03% |
| 1997-12-31 | $162.70 Million | $31.80 Million | 0.195x | +19.69% |
| 1996-12-31 | $158.60 Million | $25.90 Million | 0.163x | +140.15% |
| 1995-12-31 | $75.00 Million | $5.10 Million | 0.068x | -64.69% |
| 1994-12-31 | $43.10 Million | $8.30 Million | 0.193x | +26.69% |
| 1993-12-31 | $37.50 Million | $5.70 Million | 0.152x | +63.40% |
| 1992-12-31 | $38.70 Million | $3.60 Million | 0.093x | +125.91% |
| 1991-12-31 | $34.00 Million | $1.40 Million | 0.041x | -89.86% |
| 1990-12-31 | $12.80 Million | $5.20 Million | 0.406x | -- |
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation an… Read more